Clinical Risk Factors for Primary Graft Dysfunction after Lung TransplantationJoshua M. Diamond, Jason D. Christie, Ejigayehu Demissie et al.|American Journal of Respiratory and Critical Care Medicine|2013Cited by 686
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant RecipientsCaroline X. Qin, Dorry L. Segev, Linda W. Moore et al.|Transplantation|2021Cited by 162
SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipientsAndrew M. Hallett, Errol L. Bush, Ross S. Greenberg et al.|The Journal of Heart and Lung Transplantation|2021Cited by 65
COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron SurgeWilla Cochran, Robin K. Avery, Sonsoles Salto‐Alejandre et al.|Transplantation|2022Cited by 25
Perivaccination Antimetabolite Hold and Third Dose of SARS-CoV-2 Vaccine in Lung Transplant Recipients: Preliminary ReportSarah Frey, Pali D. Shah, Jessica M. Ruck et al.|Transplantation|2022Cited by 5